1428765-42-7

Basic information

• Product Name: phenyl 3-methyl-4-(methylsulfonamidomethyl)phenyl carbamate
• Synonyms: phenyl 3-methyl-4-(methylsulfonamidomethyl)phenyl carbamate
• CAS NO: 1428765-42-7
• Molecular Weight: 334.396
• Mol File: 1428765-42-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: phenyl 3-methyl-4-(methylsulfonamidomethyl)phenyl carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: phenyl 3-methyl-4-(methylsulfonamidomethyl)phenyl carbamate(1428765-42-7)
• EPA Substance Registry System: phenyl 3-methyl-4-(methylsulfonamidomethyl)phenyl carbamate(1428765-42-7)

Safety Data

• Hazardous Substances Data: 1428765-42-7(Hazardous Substances Data)

Upstream product

• 1428765-41-6 N-(4-amino-2-methylbenzyl)methanesulfonamide 
• 1885-14-9 phenyl chloroformate 
• 1428765-40-5 N-(2-methyl-4-nitrobenzyl)methanesulfonamide 
• 771574-01-7 (2-methyl-4-nitrophenyl)methanamine 
• 89001-53-6 2-cyano-5-nitrotoluene 
• 5326-38-5 2-iodo-5-nitrotoluene 
• 99-52-5 2-methyl-4-nitro-benzenamine 

Downstream Products

• 1428764-96-8 N-(2-methyl-4-(3-((2-m-tolyl-6-(trifluoromethyl)pyridin-3-yl)methyl)ureido)benzyl)methanesulfonamide 
• 1428789-93-8 N-(2-methyl-4-(3-((2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methyl)ureido)benzyl)methanesulfonamide 
• 1428789-92-7 N-(2-methyl-4-(3-((2-(pyrrolidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methyl)ureido)benzyl)methanesulfonamide 

Relevant articles and documents

Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands

The invention relates to aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

Amine Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands

The invention relates to amine substituted methanesulfonamide derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.